Esperion Therapeutics Inc (NASDAQ:ESPR)

BATS BZX Real-Time Price
As of 3:52pm ET
 +0.065 / +5.12%
Today’s Change
Today|||52-Week Range

Stock Price Forecast

The 8 analysts offering 12-month price forecasts for Esperion Therapeutics Inc have a median target of 7.00, with a high estimate of 22.00 and a low estimate of 2.00. The median estimate represents a +424.34% increase from the last price of 1.34.

Analyst Recommendations

The current consensus among 9 polled investment analysts is to Buy stock in Esperion Therapeutics Inc. This rating has held steady since November, when it was unchanged from a Buy rating.Move your mouse over past
months for detail


Earnings and Sales Forecasts

Current Quarter

Earnings per Share
Reporting Date
Feb 20

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly -13.49%
Growthannually 36.28%


Growthquarterly 2.19%
Growthannually 50.40%
Key to the earnings and sales forecast charts.